论文部分内容阅读
2007年6月1日雅培公司宣布,已经完成向美国FDA递交关于其生产的治疗冠心病的XIENCEV依维莫司洗脱支架
June 1, 2007 Abbott Laboratories Inc. announced that it has completed delivery of the XIENCEV everolimus-eluting stent to the U.S. FDA for the treatment of coronary heart disease